Occurrence of CNS demyelinating disease in patients with myasthenia gravis.
Kister
I
I
Herbert
J
J
Swerdlow
M L
ML
Bergamaschi
R
R
Piccolo
G
G
Oger
J
J
D001323:Autoantibodies / Q000032:analysis* / Q000097:blood / Q000276:immunology; D003937:Diagnosis, Differential; D006801:Humans; D009157:Myasthenia Gravis / Q000150:complications* / Q000276:immunology / Q000503:physiopathology; D009188:Myelitis, Transverse / Q000175:diagnosis / Q000276:immunology / Q000503:physiopathology; D009471:Neuromyelitis Optica / Q000175:diagnosis* / Q000276:immunology* / Q000503:physiopathology; D009900:Optic Nerve / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D011183:Postoperative Complications / Q000276:immunology* / Q000503:physiopathology / Q000517:prevention & control; D011237:Predictive Value of Tests; D017634:Self Tolerance / Q000276:immunology; D013116:Spinal Cord / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D013934:Thymectomy / Q000009:adverse effects*
D001323:Autoantibodies